2025 annual financial data
Arbutus Biopharma 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -281.45%.
Operating income was -27,051,000 USD and net income was -33,501,000 USD.
Operating cash flow was -39,637,000 USD.
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,083,000 USD
- Operating income
- -27,051,000 USD
- Net income
- -33,501,000 USD
- Operating cash flow
- -39,637,000 USD